Navigation Links
Spheris Reports Fourth Quarter and Year-End 2007 Results
Date:3/26/2008

5,838

Total current liabilities 26,726 26,233

Long-term debt and capital lease

obligations, net of current portion 191,761 193,942

Deferred tax liabilities 92 6,180

Other long-term liabilities 4,857 2,755

Total liabilities 223,436 229,110

Common stock, $0.01 par value, 100 shares

authorized, 10 shares issued and

outstanding - -

Other comprehensive income (loss) 564 (474)

Contributed capital 111,158 110,787

Accumulated deficit (35,036) (23,675)

Total stockholders' equity 76,686 86,638

Total liabilities and stockholders' equity $300,122 $315,748

SPHERIS INC.

Condensed Consolidated Statements of Cash Flows

(Amounts in Thousands)

Year Ended December 31,

2007 2006

Cash flows from operating activities:

Net loss $(11,361) $(12,150)

Adjustments to reconcile net loss to net cash

provided by operating activities:

Depreciation and amortization 24,273 26,553

Write-off and amortization of acquired

technology 648 736

Deferred taxes (6,435) (5,489)

Amortization of debt discounts and

issuance costs 833 756

Loss on debt refinancing 1,8
'/>"/>

SOURCE Spheris
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Spheris Sets Fourth Quarter 2007 Earnings Release and Conference Call Dates
2. Spheris Elects New Board Member
3. NeurogesX Reports Fourth Quarter and Year-End 2007 Financial Results
4. QMed, Inc. Reports Year-End and Fourth Quarter Results
5. Pelosi Statement on Social Security and Medicare Trustees Reports
6. NASI Experts Available to Comment on 2008 Social Security and Medicare Trustees Reports
7. SPO Medical Reports 2007 Sales: Growth of 35% Compared to 2006
8. Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
9. U.S. Army Study Reports WoundStat(TM) is Most Effective
10. CryoCor Reports 2007 Results
11. IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)... team of researchers from Monash University, The B...cal School and Vanda Pharmaceuticals has found a n...d sleep disorders caused by shift work. , Dr Sh...f Psychology, Psychiatry and Psychological Medicin... receptors in the brain, could be a highly effecti...
(Date:12/2/2008)..., members of SEIU 721, Ask for an Injunction in Fe...ERSIDE, Calif., Dec. 2 ...the Riverside County Regional Medical Center, file...awsuit in federal court Monday to stop the county ... , , Three nurses, who are seeking to repre...
(Date:12/2/2008)... COLUMBIA, Mo. The statistics for sexual assault... that one in five college women will be the victim...r college years. In a new study, researchers from ...ouri, have found that college women often are unaw... recognize the risk of certain behaviors, includin...
(Date:12/2/2008)... (Embargoed for Tuesday, December 2, 2008 at 3 pm...om the Medical University of South Carolina in Cha...he risk of cancer from exposure to radiation durin...as been overstated and that new estimates are seve...ons. The MUSC researchers presented their finding...
Breaking Medicine News(10 mins):Health News:New medication brings hope of jet lag cure 2Health News:Riverside County Registered Nurses File a Lawsuit to Stop County's Violation of Federal Law 2Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 2Health News:MU researcher calls for increase in sexual assault awareness programs on college campuses 3Health News:Radiological Society of North America research: Cancer risk from cardiac CT overstated 2
...ght out its version of bird flu, a blur of fact an...ublic//. "Fatal Contact: Bird Flu in America," an...s scientists are to begin testing of wild birds in...f bird flu in North America. Scientists fear the b...
...ted to analyze the incidence of adverse drug react...ore common in blacks and those of an East Asian or...British Medical Journal. The results of the prese... ethnicity may play a crucial role in determining ...
... University of Michigan Kellogg Eye Center have be...velops into a mature one and then goes about doing...o catch the cell when it had been assigned a parti...ing up to do it. The study also looked at the rol...
...dy conducted by The Royal College of Midwives has ...o stay out of the labor room//. Nearly 38% of the ...mebody else in the delivery room. Surprisingly, o... delivery room felt that they were useless during ...
Other Medicine News:Health News:Bird Flu: Fact or Fiction 2Health News:Bird Flu: Fact or Fiction 3Health News:The ABC Of Photoreceptors In The Eye 2
(Date:12/1/2008)...te Ltd today announced the initiation of a Phase 1...ctive JAK2 inhibitor, in leading medical centers i...yelofibrosis (CIMF). , , The trial is desi...1518 in patients with CIMF and is expected to enro...y will assess the safety profile and evaluate the ...
(Date:12/1/2008)...ith ENB-0040 at Children,s Hospital, Health Scienc... Enobia Pharma, an emerging Canadia...apeutics for serious bone disorders, today announc...rogram for hypophosphatasia was dosed. Enobia is i... ENB-0040 for the treatment of this rare and often...
(Date:12/1/2008)... , , ROCHESTER, Minn., Dec. 1 /PRNewswire-...the use of the drug therapy etanercept ineffective...ation of the liver caused by excessive consumption...d in the December issue of Gastroenterology ( ht...LERT: Additional audio and video resources, includ...
(Date:12/1/2008)...swire-FirstCall/ -- Following a,Request for Propo...VA-based,third generation smallpox vaccine, Publ...f of the Canadian Department of National Defence, ... delivery of IMVAMUNE(R). , The Canadian au...,country,s bio-preparedness programme. , T...
Breaking Medicine Technology:S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3The impact of physical activity on weight bearing knee joint 2297 1The impact of physical activity on weight bearing knee joint 2297 2The impact of physical activity on weight bearing knee joint 2297 3Babies raised in bilingual homes learn new words differently than infants learning one language 2295 1Babies raised in bilingual homes learn new words differently than infants learning one language 2295 2Babies raised in bilingual homes learn new words differently than infants learning one language 2295 3Painful condition affecting kidney failure patients increases risk of death 2293 1Painful condition affecting kidney failure patients increases risk of death 2293 2Painful condition affecting kidney failure patients increases risk of death 2293 3APHA Urges President Bush Not To Veto CHIP 3B Were Only One Signature Away from Protecting the Health of Our Children 2291 1APHA Urges President Bush Not To Veto CHIP 3B Were Only One Signature Away from Protecting the Health of Our Children 2291 2
... WIRE)--Mar 26, 2007 - Inovio Biomedical Corp.,(AM...A vaccines and,a novel solid tumor ablation therap...s published a scientific paper prepared by,Inovio,...om a,non-human primate study of an investigational...omedical,s electroporation technology.,The paper, ...
...Outpatient Infusion Study in Patients with,Chronic...ican,College of Cardiology 56th Annual Scientific ... March 25, 2007,/PRNewswire/ -- Scios Inc. announc... study of nesiritide (NATRECOR(R)) showed a,neutra...eath and,cardiorenal hospitalization at 12 weeks, ...
Other Medicine Technology:Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 2Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 3Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 2Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 3Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 4Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 5Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 6Scios Announces Results From Exploratory Nesiritide Study Providing,Important New Renal and Mortality Safety Data with a Neutral Effect,on the Primary Endpoint 7
...fely, the Hoefer GD 2000 uses a dry-heat vacuum me...through a heavy aluminum platen. , Dries acrylami...as thirty minutes., The heavy aluminum platen prov...bution under the gel., A clear silicone cover shee...
...ilizes a hot air drying device for polyacrylamide ...g frames at once. Gels are dried on a clear cellop...is recessed to provide a smooth, flat assembly sur...m includes a gel drying oven, 2 drying frames, 16 ...
The PRO6000 power supply is the latest edition to Thermo's power supply product offering. It sets new standards in proteomic and genomic electrophoresis. This product has unique features dedicated to
Capable of producing up to 500 volts and 500 milliamps, this power supply is ideal for PAGE, SDS-PAGE, DNA or RNA submarine gels as well as all types of small format transfer apparatus.
Medicine Products: